Literature DB >> 19325487

Differences in immune response may explain lower survival among older men with pneumonia.

Michael C Reade1, Sachin Yende, Gina D'Angelo, Lan Kong, John A Kellum, Amber E Barnato, Eric B Milbrandt, Christopher Dooley, Florian B Mayr, Lisa Weissfeld, Derek C Angus.   

Abstract

OBJECTIVE: Lower life expectancy in men is generally attributed to higher likelihood of risky behavior and because men develop chronic conditions earlier. If sex-related differences in survival are independent of preinfection chronic health and health behavior, it would suggest that survival differences may occur because of sex differences in quality of care and biological response to infection, and these differences may contribute to sex differences in life expectancy. We assessed if sex-related survival difference following community-acquired pneumonia (CAP) is due to differences in clinical characteristics, quality of care, or immune response. DESIGN, SETTING, AND
SUBJECTS: Prospective observational cohort of 2183 subjects with CAP.
MEASUREMENTS AND MAIN RESULTS: Mean age was 64.9 years. Men were more likely to smoke and had more comorbidity compared with women. At emergency department presentation, men had different biomarker patterns, as evidenced by higher inflammation (tumor necrosis factor, interleukin [IL]-6, and IL-10) and fibrinolysis (d-dimer), and lower coagulation biomarkers (antithrombin-III and factor IX) (p < 0.05). Small differences in favor of men were seen in care quality, including antibiotic timing and compliance with American Thoracic Society guidelines. Men had lower survival at 30, 90, and 365 days. The higher 1-year mortality was not attenuated when adjusted for differences in demographics, smoking, resuscitation, insurance, and vaccination status, comorbidity, hospital characteristics, and illness severity (unadjusted hazard ratio [HR] = 1.35, p = 0.003; and adjusted HR = 1.29, p = 0.004). HR was no longer statistically significant when additionally adjusted for differences in emergency department concentrations of tumor necrosis factor, IL-6, IL-10, d-dimer, antithrombin-III, and factor IX (adjusted HR = 1.27, p = 0.17). Patterns of biomarkers observed in men were associated with worse survival for 1 year.
CONCLUSIONS: Lower survival among men following CAP was not explained by differences in chronic diseases, health behaviors, and quality of care. Patterns of inflammatory, coagulation, and fibrinolysis biomarkers among men may explain reduced short-term and long-term survival.

Entities:  

Mesh:

Year:  2009        PMID: 19325487      PMCID: PMC2760065          DOI: 10.1097/CCM.0b013e31819da853

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  32 in total

1.  Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.

Authors:  T D Crabtree; S J Pelletier; T G Gleason; T L Pruett; R G Sawyer
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

Review 2.  Gender dimorphism following injury: making the connection from bench to bedside.

Authors:  Jason L Sperry; Joseph P Minei
Journal:  J Leukoc Biol       Date:  2007-09-25       Impact factor: 4.962

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.

Authors:  W A Knaus; D P Wagner; E A Draper; J E Zimmerman; M Bergner; P G Bastos; C A Sirio; D J Murphy; T Lotring; A Damiano
Journal:  Chest       Date:  1991-12       Impact factor: 9.410

5.  Estradiol is associated with mortality in critically ill trauma and surgical patients.

Authors:  Addison K May; Lesly A Dossett; Patrick R Norris; Erik N Hansen; Randalyn C Dorsett; Kimberley A Popovsky; Robert G Sawyer
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

6.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

Authors:  M R Pinsky; J L Vincent; J Deviere; M Alegre; R J Kahn; E Dupont
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

7.  Comparison of Cox and Gray's survival models in severe sepsis.

Authors:  Jan Kasal; Zorana Jovanovic; Gilles Clermont; Lisa A Weissfeld; Vladimir Kaplan; R Scott Watson; Derek C Angus
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

8.  Test of the National Death Index and Equifax Nationwide Death Search.

Authors:  J W Rich-Edwards; K A Corsano; M J Stampfer
Journal:  Am J Epidemiol       Date:  1994-12-01       Impact factor: 4.897

9.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

Authors:  John A Kellum; Lan Kong; Mitchell P Fink; Lisa A Weissfeld; Donald M Yealy; Michael R Pinsky; Jonathan Fine; Alexander Krichevsky; Russell L Delude; Derek C Angus
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

10.  Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].

Authors:  Gary T Kinasewitz; S Betty Yan; Bruce Basson; Philip Comp; James A Russell; Alain Cariou; Suzane L Um; Barbara Utterback; Pierre-Francois Laterre; Jean-François Dhainaut
Journal:  Crit Care       Date:  2004-02-10       Impact factor: 9.097

View more
  26 in total

Review 1.  The effects of estrogen on various organs: therapeutic approach for sepsis, trauma, and reperfusion injury. Part 1: central nervous system, lung, and heart.

Authors:  Takashi Kawasaki; Irshad H Chaudry
Journal:  J Anesth       Date:  2012-06-23       Impact factor: 2.078

Review 2.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

Review 3.  Statins for community-acquired pneumonia: current state of the science.

Authors:  D Viasus; C Garcia-Vidal; F Gudiol; J Carratalà
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-27       Impact factor: 3.267

4.  Prognostic factors for gastrectomy in elderly patients.

Authors:  Shunji Endo; Yukinobu Yoshikawa; Nobutaka Hatanaka; Tsutomu Dousei; Terumasa Yamada; Junichi Nishijima; Wataru Kamiike
Journal:  Int Surg       Date:  2014 Mar-Apr

Review 5.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

6.  Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children.

Authors:  Georges Ja Casimir; Fabienne Heldenbergh; Laurence Hanssens; Sandra Mulier; Claudine Heinrichs; Nicolas Lefevre; Julie Désir; Francis Corazza; Jean Duchateau
Journal:  J Inflamm (Lond)       Date:  2010-06-02       Impact factor: 4.981

7.  Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.

Authors:  Evagelia C Laiakis; Gerard A J Morris; Albert J Fornace; Stephen R C Howie
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

8.  Sex- and diagnosis-dependent differences in mortality and admission cytokine levels among patients admitted for intensive care.

Authors:  Christopher A Guidry; Brian R Swenson; Stephen W Davies; Lesly A Dossett; Kimberley A Popovsky; Hugo Bonatti; Heather L Evans; Rosemarie Metzger; Traci L Hedrick; Carlos A Tache-Léon; Tjasa Hranjec; Irshad H Chaudry; Timothy L Pruett; Addison K May; Robert G Sawyer
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

9.  Burden of Pneumonia-Associated Hospitalizations: United States, 2001-2014.

Authors:  Brandon H Hayes; Dana L Haberling; Jordan L Kennedy; Jay K Varma; Alicia M Fry; Neil M Vora
Journal:  Chest       Date:  2017-10-07       Impact factor: 9.410

10.  Xist attenuates acute inflammatory response by female cells.

Authors:  Botros B Shenoda; Sujay Ramanathan; Richa Gupta; Yuzhen Tian; Renee Jean-Toussaint; Guillermo M Alexander; Sankar Addya; Srinivas Somarowthu; Ahmet Sacan; Seena K Ajit
Journal:  Cell Mol Life Sci       Date:  2020-03-19       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.